Pathologic study of primary biliary cirrhosis of early histologic stages presenting cholestatic jaundice

Abstract

ABSTRACT— While cholestatic jaundice usually develops in the advanced stages of primary biliary cirrhosis, our series of this disease disclosed that 8 of the 88 cases presented cholestatic jaundice in the early histologic stages (stages 1 and 2). These patients frequently presented esophageal varices (57%) and showed a low incidence of positive mitochondrial antibodies compared to the non‐jaundiced cases in the same histologic stages. Histologic changes of livers from the jaundiced patients failed to show fundamental differences from those of the non‐jaundiced patients, except for the presence of bile plugs and extensive bile duct loss in the former. Deposition of orcein‐positive granules and increased hepatic copper content, suggesting prolonged cholestasis, were rather advanced, and inflammatory changes in the portal tracts and piecemeal necrosis were rather mild in the jaundiced patients. These data suggest that cholestatic jaundice occurs in a few patients in the early histologic stages on a biopsy with extensive bile duct loss and features of prolonged cholestasis; it is not clear whether such patients are a small separate cluster in PBC, or not.

Clinicopathological Factors Predicting Long‐term Overall Survival after Hepatectomy for Peripheral Cholangiocarcinoma

“…In Japan and the United Kingdom, both sexes affected equally by PCC, although men are more commonly affected by the hilar type than women [27]. In the study, men with PCC undergoing hepatectomy had better long-term overall survival, but this was not an independent variable Mucobilia occurs in various conditions, including biliary papillomatosis, cholangiocarcinoma, and biliary cystadenoma and cystadenocarcinoma of the liver [28].…”

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis

“…A premature ductopenic variant has been described in about 5-10% of patients, and it is characterized by a rapid onset of BDL in the absence of significant fibrosis, icteric cholestasis, and a rapid progression towards cirrhosis 3 , 30 .…”

Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)

“…111 Regular administration of sufficient UDCA dosage may not improve the degree of bile duct loss. 112 In view of the association of bile duct loss with persistent cholestasis and refractory jaundice, 113 the degree of bile duct loss has been identified as one of the markers of disease staging in patients with PBC. 114…”